| Issue Date |
Title |
Author(s) |
| 11-May-2020 |
Active SB-P Versus Conventional Approach to the Protection of High -Risk Side Branches The CIT-RESOLVE Trial |
Dou, Kefei;Zhang, Dong;Pan, Hongwei;Guo, Ning;Li, Lang;Li, Yue;Zhang, Qi;Liu, Bin;Shen, Zhujun;Zhang, Bin;Liu, Jian;Han, Wei;Wang, Yang;Zhao, Yanyan;Yang, Yuejin;Chen, Shaoliang;Xie, Lihua;Guan, Changdong;Kirtane, Ajay J.;Xu, Bo |
| 2013 |
The Association between Atherosclerotic Renal Artery Stenosis and Acute Kidney Injury in Patients Undergoing Cardiac Surgery |
Yang, Jingang;Lu, Changlin;Yan, Li;Tang, Xinran;Li, Wei;Yang, Yuejin;Hu, Dayi |
| 2010 |
Atherosclerotic Plaque Morphology and Serous Hypersensitive C-Reactive Protein in Patients with Premature Coronary Heart Disease |
Gao, Lijian;Xie, Rongai;Chen, Jun;Chen, Jilin;Yang, Yuejin;Bo Xu;Qiao, Shubin;Li, Jianjun;Qian, Jie;Gao, Runlin |
| 2015 |
Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease ABSORB China Trial |
Gao, Runlin;Yang, Yuejin;Han, Yaling;Huo, Yong;Chen, Jiyan;Yu, Bo;Su, Xi;Li, Lang;Kuo, Hai-Chien;Ying, Shih-Wa;Cheong, Wai-Fung;Zhang, Yunlong;Su, Xiaolu;Xu, Bo;Popma, Jeffery J.;Stone, Gregg W. |
| Sep-2020 |
China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trial |
Xu, Yi;Li, Xiangdong;Zhang, Haitao;Wu, Yuan;Zhang, Jun;Li, Jia;Dou, Kefei;Yan, Hongbing;You, Shijie;Yang, Yanmin;Liang, Yan;Xu, Lianjun;Gao, Xiaojin;Liu, Chen;Dong, Qiuting;Zhang, Wenjia;Song, Guangyuan;Zhang, Tao;Jiang, Lin;Chen, Guihao;Tang, Ruijie;Jin, Chen;Yang, Jingang;Yao, Chen;Xian, Ying;Peterson, Eric D.;Gao, Runlin;Yang, Yuejin |
| 2010 |
Chronic Kidney Disease, All-Cause Mortality and Cardiovascular Mortality Among Chinese Patients with Established Cardiovascular Disease |
Yang, Jin-gang;Li, Jue;Lu, Changlin;Hasimu, Buaijiaer;Yang, Yuejin;Hu, Dayi |
| 2018 |
Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial |
Xu, Bo;Yang, Yuejin;Han, Yaling;Huo, Yong;Wang, Lefeng;Qi, Xiangqian;Li, Jifu;Chen, Yundai;Kuo, Hai-Chien;Ying, Shih-Wa;Cheong, Wai-Fung;Zhang, Yunlong;Su, Xiaolu;Popma, Jeffery J.;Gao, Runlin;Stone, Gregg W. |
| 2009 |
Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: Results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study |
Bi, Yufang;Gao, Runlin;Patel, Anushka;Su, Steve;Gao, Wei;Hu, Dayi;Huang, Dejia;Kong, Lingzhi;Qi, Wenhang;Wu, Yangfeng;Yang, Yuejin;Turnbull, Fiona |
| 2014 |
In-hospital death causes of acute myocardial infarction after primary PCI: retrospective analysis from Beijing PCI registry 2010-2013 |
Song, Lei;Yang, Yuejin;Lv, Shuzheng;Wang, Lefeng;Gao, Wei;Guo, Jincheng;Hao, Hengjian;Fang, Quan;Wu, Mingying;Li, Hongwei |
| 2012 |
Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial |
Xu, Bo;Dou, Kefei;Yang, Yuejin;Lv, Shuzheng;Wang, Lefeng;Wang, Haichang;Li, Zhanquan;Wang, Lei;Chen, Yundai;Huo, Yong;Li, Wei;Kirtane, Ajay J.;Gao, Runlin |
| 2012 |
NOYA I: A Prospective Randomized Trial of the Biodegradable Polymer NOYA Sirolimus-Eluting Stent Compared with the Durable Polymer FIREBIRD 2 Sirolimus-Eluting Stent in Patients with Coronary Artery Disease: 9-Month Angiographic and 24-Month Clin |
Xu, Bo;Dou, Kefei;Yang, Yuejin;Lu, Shuzheng;Wang, Lefeng;Wang, Haichang;Li, Zhanquan;Wang, Lei;Chen, YunDai;Huo, Yong;Kirtane, Ajay;Gao, Run-Lin |
| 2013 |
One-year cardiovascular event rates in Chinese patients with atherothrombotic disease |
Yang, Jingang;Yang, Yuejin;Gu, Hongqiu;Li, Wei;Hu, Dayi |
| 2017 |
A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study |
Han, Yaling;Liu, Haiwei;Yang, Yuejin;Zhang, Jian;Xu, Kai;Fu, Guosheng;Su, Xi;Jiang, Tiemin;Pang, Wenyue;Chen, Jiyan;Yuan, Zuyi;Li, Hui;Wang, Haichang;Hong, Tao;Liu, Huiliang;Sun, Fucheng;Allocco, Dominic J.;Zhang, Mingdong;Dawkins, Keith D. |
| 2013 |
Safety and Efficacy of a Novel Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Lesions: 12-Month Results from the Prospectively Patient-Level Pooled Analysis of the TARGET I and TARGET I |
Gao, Run-Lin;Xu, Bo;Lansky, Alexandra;Yang, Yuejin;Zhang, Ruiyan;Ma Changsheng;Li, Hui;Chen, Shao Liang;Han, Yaling;Yuan, Zuyi;Huo, Yong;Li, Wei;Zhao, Yelin;Leon, Martin |
| 2014 |
Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 2-year results from the prospectively patient-level pooled analysis of the TARGET I and TARGET II |
Zhao, Yelin;Xu, Bo;Yang, Yuejin;Huo, Yong;Lansky, Alexandra;Leon, Martin;Guan, Changdong |
| 2013 |
Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Coronary Artery Lesions: The TARGET I Trial |
Xu, Bo;Gao, Run-Lin;Lansky, Alexandra;Yang, Yuejin;Ma Changsheng;Han, Yaling;Chen, Shao Liang;Li, Hui;Zhang, Ruiyan;Fu, Guosheng;Yuan, Zuyi;Huo, Yong;Li, Wei;Zhao, Yelin;Leon, Martin |
